Smart Home Healthcare Market Size and Share

Smart Home Healthcare Market Analysis by Mordor Intelligence
The smart home healthcare market size was valued at USD 27.97 billion in 2025 and estimated to grow from USD 35.41 billion in 2026 to reach USD 115.12 billion by 2031, at a CAGR of 26.62% during the forecast period (2026-2031). Growing elderly and chronically ill populations, payer support for remote monitoring, and rapid 5G-plus connectivity upgrades place home-based care at the center of mainstream health-system strategy. Device makers focus on artificial-intelligence–driven analytics and seamless interoperability to turn once-episodic measurements into continuous decision support. Regulators now view cybersecurity as a core safety element, while supply-chain pressures push manufacturers toward localized production. Together these forces convert home healthcare from a convenience add-on to a structural pillar of modern care delivery.
Key Report Takeaways
- By product category, Smart Glucose Monitoring Systems led with 23.60% revenue share in 2025; Continuous Glucose Monitoring is projected to advance at a 27.52% CAGR to 2031.
- By technology, wireless solutions held 60.25% of the smart home healthcare market share in 2025, while the segment is growing at 27.85% through 2031.
- By end user, the elderly segment accounted for 45.30% of the smart home healthcare market size in 2025; the disabled and mobility-impaired segment is expanding at 27.31% CAGR between 2026 and 2031.
- By application, health-status monitoring captured 27.10% of the smart home healthcare market size in 2025; remote patient management shows the fastest expansion at 27.22% CAGR through 2031.
- By geography, North America commanded 41.35% of the smart home healthcare market in 2025, while Asia Pacific is forecast to grow at 28.36% CAGR to 2031
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.
Global Smart Home Healthcare Market Trends and Insights
Drivers Impact Analysis*
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Aging population and chronic disease burden | +8.2% | Global, concentration in North America, Europe, Japan | Long term (≥ 4 years) |
| Accelerating IoT and AI integration in home-care devices | +6.8% | Global, led by North America and Asia Pacific | Medium term (2–4 years) |
| Shift to value-based reimbursement and telehealth coverage expansion | +5.4% | North America, Europe, emerging Asia Pacific | Medium term (2–4 years) |
| Cost advantage over facility-based care | +4.1% | Global, high-cost health markets | Long term (≥ 4 years) |
| Voice-assistant-enabled passive monitoring | +2.3% | North America, Europe, urban Asia Pacific | Short term (≤ 2 years) |
| Insurer wellness-IoT incentive programs | +1.8% | North America, select Europe | Medium term (2–4 years) |
| Source: Mordor Intelligence | |||
Aging Population and Chronic Disease Burden
One in five United States residents will be over 65 by 2030, and 85% of that cohort already lives with at least one chronic condition, pushing healthcare demand beyond existing facility capacity.[1]Nature Editorial Team, “The Demographic Time Bomb,” Nature, nature.com Japan already sees 29% of its citizens above 65, spurring pharmaceutical–technology collaborations that bring digital therapeutics into homes. Physician shortfalls projected at 139,000 by 2033 make smart devices an access necessity rather than a lifestyle upgrade. Programs such as Singapore’s Silver Infocomm Initiative pair tech-savvy youth with seniors, proving social support is a precondition for technology uptake. As demographics tighten, structural demand will keep the smart home healthcare market on an upward curve well past standard technology cycles.
Accelerating IoT and AI Integration in Home-Care Devices
Dexcom’s late-2024 launch of a generative-AI glucose platform demonstrates how machine learning contextualizes biosensor data into personalized insights.[2]Michael Smith, “Generative AI in Glucose Biosensing,” Dexcom Press Release, dexcom.com Samsung’s non-invasive glucose patents integrate predictive algorithms that address accuracy concerns flagged by the FDA, indicating AI now solves hardware limits rather than merely reporting data. Upcoming 6G networks promise near-instant bandwidth for large sensor arrays, giving clinicians seamless in-home visibility. Modular IoT nursing platforms already plug into existing electronic medical records through standardized APIs, suggesting that interoperability hurdles are easing. As each new device enriches shared data pools, value grows exponentially, reinforcing rapid adoption across multiple care pathways.
Shift to Value-Based Reimbursement and Telehealth Coverage Expansion
The 2025 Medicare Physician Fee Schedule keeps non-behavioral telehealth unfettered by geography through March 2025 and makes caregiver training billable, guaranteeing revenue for virtual chronic-care services. French national coverage for Dexcom ONE sensors extends continuous glucose monitoring to 100,000 basal-insulin users, the first such European reimbursement. Hypertension remote-monitoring pilots show a 22.2% ROI, which strengthens payer confidence in at-home models. With actuarial evidence showing USD 6,723 per-patient savings in heart-failure programs, payers and providers alike see connected devices as budget protectors. Reliable reimbursement removes a key barrier to scaling the smart home healthcare market.
Cost Advantage Over Facility-Based Care
UMass Chan Medical School’s “SNF at home” trials replace skilled-nursing beds with remote therapy, easing shortages and trimming per-episode costs. Hospitals leverage analytics platforms to optimize staffing and supply procurement, cutting operational expenses. Medtronic responds to chip inflation by shifting toward localized fabrication, maintaining price competitiveness while securing supply. Smart nursing-home retrofits lift build costs 18.35%, yet long-run savings from lower staff ratios and fewer safety incidents offset the premium.[3]Anna Miller, “Wearable Privacy Gaps,” MDPI Cryptography, mdpi.com Economies of scale and learning curves will keep driving device unit costs down, widening the cost gulf versus facility-centric care.
Restraints Impact Analysis*
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Data-privacy and cybersecurity concerns | -4.6% | Global, heightened in Europe and North America | Medium term (2–4 years) |
| Device-integration and interoperability gaps | -3.8% | Global, multi-vendor systems | Long term (≥ 4 years) |
| Care-giver digital-literacy barriers | -2.9% | Global, rural and underserved areas | Medium term (2–4 years) |
| Battery-life / maintenance burden for 24-7 sensors | -1.7% | Global, continuous monitoring | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
Data-Privacy and Cybersecurity Concerns
The FDA’s 2024 draft guidance now requires cybersecurity management plans and software bills of materials for every connected device submission, lengthening development cycles and raising compliance budgets. Consumer wearables that sit outside HIPAA still collect sensitive health data, leaving users exposed in grey regulatory zones. HIPAA’s safeguard rules and GDPR’s data-minimization mandates often pull in opposite directions, complicating AI model training. Edge-processing and end-to-end encryption mitigate risks yet increase computing overhead and cost. Each new IoT endpoint is another attack vector, requiring continuous security patching that inflates total cost of ownership, tempering adoption in the smart home healthcare industry.
Device-Integration and Interoperability Gaps
Fragmented data architectures keep valuable insights locked in silos; federated learning lets institutions co-train models without sharing raw patient data but demands advanced infrastructure. The 2025 Interoperability Standards Advisory endorses FHIR and terminologies like SNOMED CT and LOINC, though adoption remains uneven. Wireless Body Area Networks wrestle with protocol choices: IEEE 802.15.6 offers throughput, while LoRaWAN sacrifices speed for battery life. Proprietary ecosystems still give suppliers a competitive edge, clashing with providers who call for open architectures. True network effects for the smart home healthcare market will emerge only when standardized data exchange is universal.
*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.
Segment Analysis
By Product: CGM Technology Drives Glucose Monitoring Leadership
Smart Glucose Monitoring Systems held 23.60% of the smart home healthcare market in 2025, and Continuous Glucose Monitoring is set to climb at 27.52% CAGR, underscoring diabetes management as the entry point for connected care. Dexcom’s USD 1.114 billion Q4 2024 revenue, up 8% year on year, validates sustained demand. Smart cardiac monitors and blood-pressure devices ride telehealth adoption, while wearable sleep trackers spill over from consumer wellness into clinical protocols. Fall sensors deploy predictive algorithms to cut false alarms, though accuracy challenges hold back mass uptake. Medical device alert hubs act as command centers, linking multiple sensors for cohesive clinician dashboards. Smart inhalers align medication adherence with AI coaching, and robotic pill dispensers solve polypharmacy complexity. Product convergence signals that future offerings will package multi-parameter sensors under unified platforms rather than discrete gadgets.
The smart home healthcare market size for glucose monitoring dwarfs niche categories and supports heavy R&D budgets. Yet, competitive advantage is shifting toward software algorithms that translate raw data into actionable insights. Patent filings from Samsung show non-invasive optical glucose methods combined with contextual data layers to meet FDA accuracy thresholds. As reliability rises, CGM platforms will anchor broader chronic-care ecosystems, helping vendors cross-sell cardiac, respiratory, and sleep modules. Continuous feedback loops between device usage and clinical outcomes strengthen payer justification for wider reimbursement, reinforcing momentum across adjacent product lines.

By Technology: Wireless Dominance Accelerates Through 6G Integration
Wireless solutions commanded 60.25% of the smart home healthcare market share in 2025 and are advancing at 27.85% CAGR, pushed by 5G rollouts and early 6G pilots promising sub-millisecond latency. Wi-Fi 6 and Bluetooth Low Energy dominate short-range transmissions, while NB-IoT extends coverage to rural patients. Zigbee and Thread serve dense in-home mesh networks that need low power and self-healing signals. Wired connections persist in high-bandwidth imaging nodes but trend downward as encryption and reliability improve over airwaves.
By 2030 the smart home healthcare market size tied to wireless backbones will exceed wired channels by a broad margin, reflecting user demand for untethered mobility. Hybrid routers automatically shift traffic among cellular, Wi-Fi, and Ethernet to preserve quality of service during clinical events. LPWAN protocols such as LoRa prove ideal for battery-free wound sensors that broadcast occasional healing data, keeping maintenance minimal. As 6G matures, simultaneous transmission of thousands of sensor streams per household becomes feasible, opening doors to ambient intelligence that predicts clinical deterioration before symptoms appear.
By End User: Disability Segment Outpaces Traditional Elderly Focus
The elderly group controlled 45.30% of the smart home healthcare market in 2025, yet the disabled and mobility-impaired cohort is growing fastest at 27.31% CAGR. Predictive informing systems interpret user intent and adjust lighting, temperature, and medication schedules, enhancing autonomy. Chronic-disease patients remain a core base, relying on continuous metrics to manage conditions without frequent clinic visits. Post-acute and rehab patients use at-home sensors to document progress, cutting readmissions. Pregnant women adopt wearable fetal monitors that leverage deep-learning temperature models to forecast labor within two days.
Smart home healthcare industry vendors widen appeal by embedding universal-design principles, making interfaces usable by people with vision, hearing, or dexterity challenges. National Health and Aging Trends data show smart adaptations lower caregiver loads and delay institutionalization. Consumer wellness users form a feeder pipeline, graduating from basic fitness trackers to medical-grade gear as health needs evolve. Inclusion-driven design therefore doubles as a market-expansion engine.

By Application: Remote Patient Management Transforms Care Delivery
Health-status monitoring captured 27.10% of the smart home healthcare market size in 2025, while remote patient management is poised for 27.22% CAGR as payers reward proactive interventions. Safety and security nodes—fall detectors, smoke alarms, door sensors—form the first layer of protection for independent living. Machine-learning classifiers now differentiate genuine falls from routine movement, improving caregiver trust. Nutrition tracking pairs CGM readings with meal photos to quantify glycemic impact, tailoring dietary advice. Memory aids using voice prompts support medication adherence and daily routines for cognitive-decline sufferers.
Rehabilitation platforms combine motion sensors and gamified exercises, providing therapists with real-time recovery scores. The MONIT smart diaper system cut dermatitis severity among cognitively impaired users, illustrating niche-yet-high-impact use cases. Successful vendors map application design to specific clinical workflows, embedding analytics that convert raw sensor pulses into actionable tasks for nurses or family members. As remote management shows tangible outcome improvements, payer coverage will expand, further accelerating the smart home healthcare market.
Geography Analysis
North America generated 41.35% of 2025 revenue for the smart home healthcare market, thanks to established broadband, favorable reimbursement, and early IoT adoption. Government policy keeps momentum high as the FDA weaves cybersecurity into core safety rules and Medicare reimburses continuous remote monitoring. Provider networks integrate smart home data into clinical dashboards, giving clinicians near-real-time visibility across large patient cohorts.
Asia Pacific is on a steeper adoption curve and is projected to grow at 28.36% CAGR through 2031. Japan’s aging society propels pharmaceutical–technology alliances that bring monitoring to living rooms. China invests in national health-data lakes that feed AI decision engines, accelerating product approvals. South Korea earmarked USD 830 million to build AI-driven emergency systems and digital-care infrastructure. India emphasizes insurance-backed telehealth solutions that extend reach in rural districts, often using low-cost smartphones rather than dedicated hardware.
Europe posts steady growth under GDPR’s stringent privacy guardrails. National funding programs accelerate electronic medical-record harmonization, yet cross-border regulatory complexity slows multinational rollouts. Scandinavia pilots voice-assistant monitoring for dementia care, while France sets reimbursement precedent for CGM devices, expanding access for basal-insulin users.
The Middle East and Africa remain nascent but show promise where mobile health platforms overcome clinician shortages. Governments explore public-private partnerships to install community telehealth kiosks that interface with in-home devices. Latin America follows a similar path, leaning on low-bandwidth protocols that fit variable connectivity. Across all regions, policy alignment, broadband density, and digital-literacy programs determine adoption speed more than sensor availability alone.

Regulatory Landscape
Connected smart home healthcare devices operate across a split regime of medical-device regulation and lower-risk wellness policies, with cybersecurity and software lifecycle controls receiving more attention. In the United States, the FDA regulates medical devices under its device framework, and as of February 2026 the Quality Management System Regulation (QMSR) became effective to align 21 CFR Part 820 with ISO 13485:2016, tightening quality-system expectations for manufacturers shipping connected monitors and hubs.
In Europe, MDR requirements continue to shape technical documentation, clinical evaluation, and post-market surveillance for home-use devices placed on the CE-marked market. Technical standards are also evolving around home interoperability and trust, with ISO/IEEE publications in September 2024 (ISO/IEEE 11073-10700:2024 and ISO/IEEE 11073-10471:2024) adding interoperability specifications relevant to independent living activity hubs. ISO/IEC TR 30123:2026 (published March 2026) provides IoT-for-home-healthcare guidance focused on trustworthiness, safety, and reliability, which helps align multi-vendor in-home architectures with regulator expectations.
Value Chain Analysis
The value chain runs from sensor and semiconductor inputs through device OEMs (glucose, cardiac, BP, respiratory, fall detection, and alert hubs), software analytics, and integrations into telehealth and hospital-at-home workflows. Downstream distribution follows provider networks, pharmacies, DME channels, and consumer retail ecosystems. Upstream dependence on micro-controllers, connectivity chips, and sensing modules ties smart home healthcare availability to broader electronics cycles, and ecosystem activity shows semiconductor suppliers moving closer to care platforms. For example, Infineon partnered with The Healthcare Impact Alliance (June 2025) to support connectivity components for the OneCare connected senior care platform.
Midstream, platform integration is increasingly used to reduce fragmentation between device data and clinical workflows. Examples include Inbound Health partnering with Biobeat (April 2025) to integrate FDA-cleared remote patient monitoring wearables into a hospital-at-home platform, and TytoCare integrating its Home Smart Clinic with Teladoc Health programs (November 2025) and partnering with VNS Health (September 2025) to deploy Pro Smart Clinic tools for medically complex patients. Implementation depends on onboarding, caregiver training, and secure home networking, while supply chain resilience efforts (including regionalization and tighter supplier qualification under ISO 13485-aligned expectations) are growing in relevance as component availability and logistics volatility can affect lead times and cost for connected devices.
Competitive Landscape
The smart home healthcare market features a mix of med-tech incumbents and consumer-tech challengers. Medtronic recorded 5.3% organic growth and 12.6% diabetes-segment expansion in FY25, fueled by MiniMed 780G automated insulin pumps. Abbott secured FDA and CE approvals for leadless pacemakers and expanded community health center partnerships to pair food security with chronic-care management. Dexcom merged biosensing with AI-driven analytics through ŌURA integration, broadening its wellness footprint while deepening clinical relevance.
Consumer giants build on existing device ecosystems. Apple layers health features onto Watch and iPhone, while Google leverages Fitbit data to feed proprietary AI coaching. Amazon’s Alexa Together uses voice cues to detect wellness changes and alert caregivers. Samsung’s push into optical glucose sensing shows the blurring line between wellness gadgets and regulated medical devices.
Start-ups attack white spaces such as battery-free wound monitors and federated-learning platforms that safeguard privacy without raw-data exchanges. Partnerships bloom across sectors: hospitals supply clinical validation, telecoms provide bandwidth, and insurers create incentive schemes. Competitive advantage is shifting toward firms mastering secure data orchestration rather than those focusing solely on hardware breakthroughs. With no single player above 15% market command, rivalry centers on speed of innovation and ecosystem breadth.
Smart Home Healthcare Industry Leaders
Sleepace
Awair Inc.
Eight Sleep
Encore Healthcare
Medtronic Plc
- *Disclaimer: Major Players sorted in no particular order

Market Opportunities and Future Outlook
Reimbursement and program design are broadening commercial pathways for home-integrated monitoring and coaching, particularly for chronic disease workflows that can be documented and billed. In the United States, CMS added new remote patient monitoring CPT codes effective January 1, 2026, and launched the ACCESS model on July 5, 2026, which gives providers and solution partners clearer ways to package devices, connectivity, and clinical services into technology-enabled care programs rather than standalone device sales.
Interoperability and security standardization also create space for vendors that can bridge consumer smart-home environments with clinical-grade expectations. ISO/IEC TR 30123:2026 (published March 2026) provides an IoT architecture reference for home healthcare, and NIST CSWP 34 (December 2025) outlines a telehealth smart home integration reference architecture centered on segmentation, identity management, and continuous monitoring, supporting offerings such as secure home gateways and managed connectivity for medical IoT. ONC's Draft USCDI Version 7 (January 2026) proposes expanded standardized data classes for patient-generated health data, supporting opportunities in data normalization, device-to-EHR pipelines, and multi-condition dashboards that reduce siloed monitoring across glucose, blood pressure, cardiac, and sleep/vital sign tracking.
Recent Industry Developments
- July 2026: CMS launched the ACCESS model to institutionalize technology-enabled chronic disease management within Medicare frameworks. The program structure strengthens the business case for bundled smart home monitoring, connectivity, and clinical services supporting longitudinal management rather than episodic measurement.
- November 2025: Awair partnered with Fitwel to integrate commercial-grade indoor air quality sensor data into the Fitwel healthy building certification platform. The partnership advances performance-based verification using continuous IAQ monitoring, which can support home-health adjacent use cases where environmental triggers affect chronic conditions and recovery at home.
- September 2024: ISO/IEEE published ISO/IEEE 11073-10700:2024 and ISO/IEEE 11073-10471:2024 to specify secure interoperability and personal health device communications relevant to independent living activity hubs. These standards reduce ambiguity for multi-vendor home monitoring architectures by clarifying how connected devices exchange data across medical IT networks.
Research Methodology Framework and Report Scope
Market Definition and Coverage
For this methodology, the smart home healthcare market covers revenue earned from connected, home-deployed healthcare devices and alert systems that monitor health status and support remote care actions in a residential setting.
Scope exclusions: We exclude in-home clinical service fees and general consumer smart home gear that is not used for healthcare monitoring or medical alerts.
Segmentation Overview
- By Product
- Medical Device Alert Systems
- Smart Glucose Monitoring Systems
- Continuous Glucose Monitoring (CGM)
- Smart Cardiac Monitoring Devices
- Smart Blood-Pressure Monitors
- Wearable Sleep and Vital-Sign Trackers
- Smart Inhalers and Respiratory Monitors
- Smart Fall Sensors
- Medication-Dispensing Robots
- Others
- By Technology
- Wireless
- Wi-Fi
- Bluetooth
- Zigbee / Thread
- Cellular / NB-IoT
- Wired
- Hybrid Networks
- Wireless
- By End User
- Elderly (65 + Independent Living)
- Chronic-Disease Patients
- Disabled / Mobility-Impaired Individuals
- Post-Acute and Rehabilitation Patients
- Pregnant Women and New Mothers
- General Wellness Users
- By Application
- Safety and Security Monitoring
- Health-Status Monitoring
- Fall Prevention and Detection
- Nutrition / Diet Tracking
- Memory Aids
- Remote Patient Management
- Rehabilitation and Chronic-Care Management
- Others
- By Geography
- North America
- United States
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Rest of South America
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- Middle East and Africa
- Middle East
- United Arab Emirates
- Saudi Arabia
- Turkey
- Rest of Middle East
- Africa
- South Africa
- Nigeria
- Kenya
- Rest of Africa
- Middle East
- North America
Data Sources, Market Sizing, and Validation
Desk Research
Desk work started with building a clear picture of the demand pool for home-based monitoring, and then mapping the device categories that typically qualify as healthcare use at home. We reviewed public health and aging indicators and then paired them with adoption signals for connected care, so inputs stayed tied to realistic household-level use.
For public sources, we leaned on materials such as the World Health Organization for aging and chronic disease context, the US CDC for health condition prevalence and falls-related statistics, and the US FDA device databases for product clearances and device-type definitions. We also used OECD health statistics, select peer-reviewed journals on remote monitoring outcomes, and government digital health portals where available. Company filings, investor presentations, earnings call notes, and credible press interviews were used to understand pricing direction and channel mix, and a paid subscription source for company financials and a patent database were selectively used to confirm R&D intensity and product roadmap signals. These examples are not exhaustive, and many other public sources were also reviewed for data collection, validation, and clarification.
Primary Interviews and Surveys
Primary work focused on pressure-testing adoption rates, average selling price ranges, and replacement cycles for the main home-use monitoring and alert categories. We spoke with a mix of device makers, distributors, clinicians involved in remote monitoring programs, and payer or provider-side roles to confirm what gets purchased and what gets reimbursed in practice. Because this is a global market, coverage was balanced across major regions so regional rollout timing and pricing differences could be reflected in the model.
Distribution of primary research fieldwork respondents
| Company type | Respondent position | Region |
|---|---|---|
| Top tier: 30% | CXOs: 13% | APAC: 38% |
| Mid tier: 55% | Functional/Unit leaders: 35% | EMEA: 35% |
| Smaller Players: 15% | Managers: 52% | Americas: 27% |
Market-Sizing & Forecasting
Sizing began with a top-down demand pool build that reconstructs addressable home-use monitoring and alert spend from chronic condition prevalence, aging population share, and the implied eligible household base that can practically use connected devices. From there, we applied category-level adoption and utilization logic for the main device groups commonly tracked in this space, such as smart glucose monitoring, smart cardiac monitoring, and medical device alert systems, and then converted units into value using realistic price bands.
To keep totals grounded, results were cross-checked through selective bottom-up approximations, including sampled price x volume checks from manufacturer disclosures, channel feedback on sell-in versus sell-through timing, and a light roll-up of known revenue exposure for companies that are primarily tied to home monitoring devices. The model uses inputs such as reimbursement momentum for remote monitoring, connectivity mix (wired versus wireless), device replacement cycles, program enrollment growth for monitored patients, and regional rollout pace for home-based care pathways. Forecasting relied on scenario analysis supported by expert views, where base case growth reflects expected device penetration gains and gradual price normalization rather than one-time spikes. Where company disclosures were incomplete, gaps were handled by using category medians validated in interviews and then re-tested against regional healthcare spending constraints.
Data Validation & Update Cycle
Outputs were checked against independent signals, including device shipment direction shared in public filings, reported growth in remote monitoring programs, and broad healthcare digitization indicators that correlate with connected care uptake. Outliers were flagged when implied per-user spend or penetration exceeded what interviews described as feasible, and then assumptions were revisited until the logic held across regions and device categories.
Before sign-off, the model goes through a multi-step review that checks arithmetic consistency, year-on-year transitions, and currency conversion timing so the series stays comparable. Reports are refreshed annually, and interim updates are triggered when material events occur, such as major reimbursement changes, regulatory actions affecting device categories, or abrupt pricing resets. Right before delivery, we perform a fresh pass to ensure the narrative and tables reflect the latest validated view.
Mordor Intelligence's Smart Home Healthcare Market Sizing Compared With Other Published Estimates
Published market values for smart home healthcare can look far apart because firms do not always count the same items, and they also pick different years, pricing assumptions, and adoption curves. We treat these differences as expected, so the comparison is used to explain what is being included and what is being left out.
Some external numbers expand the scope into home care services and broader digital health platforms, and then the total rises quickly as labor and program fees get added. For Mordor Intelligence, the count is limited to smart home healthcare devices and alert or monitoring systems used in a residential setting, with pricing aligned to typical realized selling prices and a 2025 to 2026 step checked back with interviews.
Benchmark comparison
| Source | Market Size | Gaps in Research Methodology |
|---|---|---|
| Mordor Intelligence | USD 35.41 B (2026) | |
| Industry Press Release A | USD 22.70 B (2023) | Uses an earlier base year and commonly reflects a broader interpretation that can include service-led home care revenue and platform fees, which increases coverage beyond device and alert system sales. |
| Technology Research Chart B | USD 16.80 B (2025) | Presented as device revenue only, which can exclude parts of the medical alert system category or certain monitored device groups that are counted when the market is defined around healthcare-use devices at home. |
The spread mostly comes down to what is counted and the timing of the base year, not just math. Once service revenue is separated from device sales and pricing is kept consistent with what channels report as realized levels, the market size becomes easier to reconcile and repeat year to year.
Key Questions Answered in the Report
What is the current size of the smart home healthcare market?
The market is valued at USD 35.41 billion in 2026 and is expected to reach USD 115.12 billion by 2031.
Which region is expanding fastest in the smart home healthcare market?
Asia Pacific leads growth with a projected 28.36% CAGR through 2031, propelled by national digital-health investments.
Which product segment holds the largest smart home healthcare market share?
Smart Glucose Monitoring Systems account for 23.60% of 2025 revenue, driven by continuous glucose monitoring adoption.
How do reimbursement policies influence smart home healthcare adoption?
Expanded telehealth and remote-monitoring coverage create predictable revenue streams, accelerating device deployment and patient uptake.
What are the main barriers to smart home healthcare market growth?
Data-privacy concerns, interoperability gaps, and digital-literacy challenges remain key restraints despite rapid technology advances.
Who are the major players in the smart home healthcare industry?
Medtronic, Abbott, Dexcom, Apple, Google, and Amazon lead through a combination of medical-device expertise and consumer-tech ecosystems.
Page last updated on:




